@article{b319dbb82f7345d28b461b0e3c3b2a86,
title = "PCSK9 Inhibition and Oxidized Phospholipids",
author = "Bhatia, {Harpreet S.} and Calvin Yeang and Amos Baruch and Xiaohong Yang and Stroes, {Erik S. G.} and Sotirios Tsimikas",
note = "Funding Information: Dr Bhatia was supported by National Institutes of Health Grant No. 5T32HL079891, as part of the University of California San Diego Integrated Cardiovascular Epidemiology Fellowship. Dr Tsimikas is a co-inventor of and has received royalties from patents owned by the University of California San Diego on oxidation-specific antibodies and of biomarkers related to oxidized lipoproteins; is a co-founder of and has an equity interest in Oxitope and its affiliates as well as in Kleanthi Diagnostics; and has a dual appointment at University of California San Diego and Ionis Pharmaceuticals. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Dr Bhatia was supported by National Institutes of Health Grant No. 5T32HL079891 , as part of the University of California San Diego Integrated Cardiovascular Epidemiology Fellowship. Dr Tsimikas is a co-inventor of and has received royalties from patents owned by the University of California San Diego on oxidation-specific antibodies and of biomarkers related to oxidized lipoproteins; is a co-founder of and has an equity interest in Oxitope and its affiliates as well as in Kleanthi Diagnostics; and has a dual appointment at University of California San Diego and Ionis Pharmaceuticals. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.",
year = "2021",
month = sep,
day = "21",
doi = "https://doi.org/10.1016/j.jacc.2021.07.031",
language = "English",
volume = "78",
pages = "1288--1289",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "12",
}